Home » Newsletters » BioWorld Science

BioWorld Science

July 5, 2019

View Archived Issues

Viral-MS link comes via bad memories

Gut microbiome affects food allergies

Glucagon alpha-cell proliferation declines with age

Dengue virus protein mutation increases disease severity in mice

Patient enrollment ongoing in phase I study of MBS-301

New phase IIa ELEVATE 1 study investigates RVT-1201 for pulmonary arterial hypertension

Janssen Pharmaceutica presents PRMT5 inhibitors

First patient enrolled in IBT's pivotal phase III study of IBP-9414

NeuroVive announces the initiation of the second part of its ongoing phase Ia/b study of KL-1333

Nosopharm and Evotec partner to advance development of novel antibiotics

Vaccex to initiate clinical development of VX-001

Novel ERB antibiotics show promising activity in MRSA thigh infection models

LSS biallelic pathogenic variants are associated with APMR syndrome

Novel genetic variant in CARD11 as a biomarker of profound combined immunodeficiency

SP-8356, a CD147 inhibitor, is a potential compound for treating atherosclerosis

Aquaporin-1 is a potential therapeutic target in TBI, researchers find

Bristol-Myers Squibb patents TLR7, TLR8 and/or TLR9 antagonists

Janssen Biotech patent describes hSTING agonists

REVOLUTION Medicines identifies PTPN11 inhibitors

Pyramid Biosciences synthesizes NTRK1 inhibitors

Innovate UK grant supports ROP cancer vaccine development

FDA approves Xembify for primary immunodeficiencies

WDFY3 gene variants linked to mild to moderate neurodevelopmental delay and intellectual disability

Lasmiditan for acute treatment of migraine: results from phase III trial

EMA validates clinical development program for AB-8939

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...